FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
-
Subclinical onychomycosis in patients with type II diabetes
1922PDF: 885HTML: 410 -
11 | Challenges in developing a digital pathology consultation network: insights from the MELCAYA experience Filippo Ugolini1, Dario Di Gangi2, Roberta Gugliotta3, Anna Szumera-Ciećkiewicz4|5, Llucia Alos6, Natalia Castrejón6, Stephan Forchhammer7, Barbara Valeri8, Nicolas Macagno9, Sule Ozturk Sari10, Ozge Hurdogan10, Sokol Sina11, Sylvie Fraitag12, Valerio Gaetano Vellone13, Chiara Trambaiolo13, Rita Alaggio14, Sabrina Rossi14, Giovanni Arcuri3, Daniela Massi2, Claudio Conti3 | 1Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy. 2Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy. 3UOC Direzione Tecnica, ICT ed Innovazione Tecnologie Sanitarie, Fondazione Policlinico Agostino Gemelli IRCCS, Roma, Italy. 4Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. 5Department of Pathology , Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. 6Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.7Department of Dermatology, University Medical Center, Eberhard Karls University Tübingen, Tübingen, Germany. 8Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. 9Aix-Marseille University, Marmara Institute, INSERM, U1251, MMG, DOD-CET, Marseille, France. 10Department of Pathology, Istanbul University Istanbul Medical Faculty, Istanbul, Türkiye; 11Section of Pathology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 12Pathology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France; 13Pathology Unit, IRCCS Istituto Giannina Gaslini, Genoa; 14Pathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
373 -
34 | Dissecting the spectrum of rare BRAF mutations in melanoma: a nation-wide study by the Italian Melanoma Intergroup Francesco Spagnolo1|2, Bruna Dalmasso3, Maria Chiara Scaini4, Laura Cendron5, Monica Rodolfo6, Ilaria Mattavelli7, Elena Tamborini8, Francesca Collina9, Gerardo Ferrara, Gabriele Madonna10, Carlo Cota11, Elisa Melucci12, Stefania Tommasi13, Martina Ubaldi14, Roberta Depenni15, Andrea Carugno16, Riccardo Marconcini17, Laura Orgiano18, Maurizio Lombardo19, Simona Sola20, Cristina Pellegrini21, Francesca Castiglione22, Matteo Gasparotto5|23, Alireza Jorkesh5, Stefania Pellegrini4, Edoardo Raposio1, Andrea Boutros2, Enrica Teresa Tanda2, Michele Guida25, Pietro Quaglino26, Giuseppe Palmieri27, Daniela Massi22, Paolo Antonio Ascierto10, Mario Mandalà*28, Chiara Menin*4, Paola Ghiorzo*24, Lorenza Pastorino*24, for the Italian Melanoma Intergroup29 | 1Department of Surgical Sciences and Integrated Diagnostics, DISC, Plastic Surgery Division, University of Genoa; 2IRCCS Ospedale Policlinico San Martino, Genova; 3IRCCS Ospedale Policlinico San Martino, Cancer Genetics, Genoa; 4Immunology and Molecular Oncology Unit, Veneto Institute of Oncology - IOV IRCCS, Padua; 5Department of Biology, University of Padua, Padua; 6Unit of Translational Immunology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 7Melanoma Surgical Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 8Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 9Pathology Unit, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Napoli; 10Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli; 11Dermatopathology Unit, San Gallicano Dermatological Institute IRCCS, Rome; 12Pathology Unit, IRCCS Regina Elena, National Cancer Institute, Rome; 13Molecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari; 14Unit of Medical Oncology, University of Perugia; 15Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena; 16Department of Medicine and Surgery, University of Insubria, Varese; 17Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa; 18Department of Medical Oncology, University of Cagliari, Cagliari; 19Division of Dermatology, Department of Medicine and Surgery, Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese; 20Surgical Pathology, Galliera Hospital, Genoa; 21Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila; 22Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy and Section of Pathology, Department of Health Sciences, University of Florence, Italy; 23Department of Translational Brain Research, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 24Department of Internal Medicine and Medical Specialties, University of Genoa; 25Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari; 26Dermatology Clinic, Department of Medical Sciences, University of Turin; 27Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, Sassari; 28University of Perugia, Medical Oncology Unit, Santa Maria Misericordia Hospital, Perugia; 29Italian Melanoma Intergroup, IMI, Italy. *These authors equally contributed to this work.
321 -
18 | Surgical management of pregnancy-associated melanoma: a single institution experience with thirty-three pregnant patients B. Taglione1, I. Mattavelli1, A. Maurichi1, G. Gallino1, D. Cortese1, E. Tolomio1, G. Spadola1, C. Barbieri1, S. Mercurio1, B. Scoppio1, B. Valeri2, M. Cossa2, M. Maccauro3, L. Di Guardo4, M. Del Vecchio4, M. Santinami1, R. Patuzzo1 | 1IRCCS Istituto Nazionale Tumori Milano, Surgery, Milano; 2IRCCS Istituto Nazionale Tumori Milano, Pathology, Milano; 3IRCCS Istituto Nazionale Tumori Milano, Nuclear Medicine, Milano; 4IRCCS Istituto Nazionale Tumori Milano, Medical Oncology, Milano, Italy.
339 -
Secondary prevention of hidradenitis suppurativa
2819PDF: 1202HTML: 26 -
10 | Prognostic value of trans epidermal water loss in the treatment of actinic keratoses. A comparison amongst topical therapies for field cancerization Matteo Bevilacqua, Filippo Fanetti, Nicolò Mori, Agata Janowska, Valentina Dini, Marco Romanelli | Department of Dermatology, University of Pisa, Pisa, Italy.
369 -
03 | Pancreatic cancer burden in Italian CDKN2a-positive families followed for up to 25 years Eleonora Allavena1|2, Bruna Dalmasso2, Andrea Gambino2, Francesca Barbero2, Irene Vanni2, Cansu Gorgun1, Francesco Spagnolo2|4, Enrica Tanda3, Andrea Boutros3, William Bruno1|2, Lorenza Pastorino1|2, Paola Ghiorzo1|2 | 1Department of Internal Medicine and Medical Specialties - DiMI, University of Genoa; 2Cancer Genetics Unit, IRCCS Ospedale Policlinico San Martino, Genoa; 3Medical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genoa; 4Department of Surgical and Diagnostic Integrated Sciences, University of Genoa, Genoa, Italy.
348
